Transcript Office of the Director - ARCHIVES - National Institute on Drug Abuse

Director’s Report to the
National Advisory Council
on Drug Abuse
May 17, 2005
Director’s Report to the
National Advisory Council on Drug Abuse
Budget Update
Policy Issues
Recent NIDA Activities
& Events
Budget Update
NIDA BUDGET
(Thousands)
2004
Actual
2005
Appropriation
2006
P.B.
NonAIDS
$677,808
$693,282
$707,026
AIDS
$312,979
$313,137
$303,104
TOTAL
$990,787
$1,006,419
$1,010,130
+3.0%
+1.2%
+0.4%
Increase Over
Prior Year
Policy Issues
NEW Supplemental Ethics Regulation
That Affects ALL NIH Employees
Sets out broad prohibitions regarding…
Outside activities
Holdings
Awards
Current Status:
Pending Response From Employees
Recent NIDA Activities
& Events
NIDA PAs and RFAs Just Issued
•
•
•
•
•
Collaborative Multisite Research in Addiction (COMRAD)
(PA-05-067)
Minority Institutions’ Drug Abuse Research Development
Program (MIDARP) (PAR-05-069)
Drug Abuse Dissertation Research: Epidemiology,
Prevention, Treatment, Services and Women and Sex/
Gender Differences (PAR-05-083)
Inhalant Abuse: Supporting Broad-Based Research
Approaches (PA-05-099)
Strategic Program for Innovative Research on Drug
Addiction Pharmacotherapy (SPIRDAP) (RFA-DA-05-009)
PAs and RFAs Recently Issued With
Other NIH Components/Agencies
13 New PAs and 4 New RFAs
Foci include:
Neurobiology
Co-morbidity
HIV/AIDS
Brain Development
Research Training
Software/Biomedical Computing
International Collaboration
National Institute on Drug Abuse
Office of the Director
Special Populations Office
Nora D. Volkow, MD
Director
Timothy P. Condon, Ph.D.
Deputy Director
Director, AIDS Research
HIV/AIDS Research
Laura S. Rosenthal
Associate Director
for Management
Dr. Jacques Normand
Will Provide an Update
Office of
Extramural
Affairs
Teresa Levitin, PhD
Division of
Basic Neurosciences
& Behavior Research
David Shurtleff, PhD
Office of Planning
& Resource
Management
Laura Rosenthal
Office of
Science Policy &
Communications
Timothy Condon, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
Division of
Epidemiology,
Services &
Prevention Research
Frank Vocci, PhD
Wilson Compton, MD, MPE
Center for the
Clinical Trials
Network
Betty Tai, PhD
Division of Clinical
Neuroscience,
Development &
Behavioral
Treatment
Joseph Frascella, PhD
Intramural
Research
Program
Barry Hoffer, MD, PhD
National Institute on Drug Abuse
Office of the Director
Special
Populations Office
Special
Population/
Health Disparities
Nora D. Volkow, MD
Director
Timothy P. Condon, Ph.D.
Deputy Director
Laura S. Rosenthal
Associate Director
for Management
Dr. Jose Szapocznik
Will Report on
Minority
Health Office of Planning
Office of
Extramural
& Resource
Disparities
Workgroup
Affairs
Management
Findings & Recommendations
Teresa Levitin, PhD
Division of
Basic Neurosciences
& Behavior Research
David Shurtleff, PhD
Director, AIDS Research
Laura Rosenthal
Office of
Science Policy &
Communications
Timothy Condon, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
Division of
Epidemiology,
Services &
Prevention Research
Frank Vocci, PhD
Wilson Compton, MD, MPE
Center for the
Clinical Trials
Network
Betty Tai, PhD
Division of Clinical
Neuroscience,
Development &
Behavioral
Treatment
Joseph Frascella, PhD
Intramural
Research
Program
Barry Hoffer, MD, PhD
National Institute on Drug Abuse
Office of the Director
Special Populations Office
Nora D. Volkow, MD
Director
Timothy P. Condon, Ph.D.
Deputy Director
Director, AIDS Research
Laura S. Rosenthal
Associate Director
for Management
Office of
Extramural
Affairs
Teresa Levitin, PhD
Division of
Basic Neurosciences
& Behavior Research
David Shurtleff, PhD
Office of Planning
& Resource
Management
Laura Rosenthal
Office of
Science Policy &
Communications
Timothy Condon, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
Division of
Epidemiology,
Services &
Prevention Research
Frank Vocci, PhD
Wilson Compton, MD, MPE
Center for the
Clinical Trials
Network
CCTN
Betty Tai, PhD
Division of Clinical
Neuroscience,
Development &
Behavioral
Treatment
Joseph Frascella, PhD
Intramural
Research
Program
Barry Hoffer, MD, PhD
The National Drug Abuse Treatment
Clinical Trials Network
(RFA-DA-05-001)
Issued July 7, 2004
Application Receipt Date: October 14, 2004
15 Applications Received -- 4 New
Applications Reviewed
13 Scored
CTN Clinical Coordinating Center
Contract Awarded to
The EMMES Corporation
CTN Data and Statistics Center (DSC)
Contract Awarded to
Duke Clinical Research Institute (DCRI)
Update on New CTN Protocols
•
•
•
•
Starting Treatment with Agonist Replacement
Therapies (START): compare the effect of
buprenorphine/naloxone and methadone on
liver function 10 sites, January 2006
Randomized Controlled Trial of Methylphenidate
in Adolescents with ADHD and Substance Use
Disorders 12 sites, Fall 2005
Methylphenidate in Maintaining Abstinence in
Smokers with ADHD 6 sites, Fall 2005
Prescription Opioid Addiction Treatment
Study (POATS) ~ 12 sites, Fall 2005
National Institute on Drug Abuse
Office of the Director
Special Populations Office
Nora D. Volkow, MD
Director
Timothy P. Condon, Ph.D.
Deputy Director
Director, AIDS Research
Laura S. Rosenthal
Associate Director
for Management
Office of
Extramural
Affairs
Teresa Levitin, PhD
Division of
Basic Neurosciences
& Behavior Research
David Shurtleff, PhD
Office of Planning
& Resource
Management
Laura Rosenthal
Office of
Science Policy &
Communications
Timothy Condon, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
Division of
Epidemiology,
Services &
Prevention Research
Frank Vocci, PhD
Wilson Compton, MD, MPE
DPMCDA
Center for the
Clinical Trials
Network
Betty Tai, PhD
Division of Clinical
Neuroscience,
Development &
Behavioral
Treatment
Joseph Frascella, PhD
Intramural
Research
Program
Barry Hoffer, MD, PhD
REPORT
from the
Medications
Development Program
Work Group
2005
National Institute
on Drug Abuse
National Institutes of Health
U.S. Department of Health and Human Services
Committee Members
Bankole Johnson, M.D., Ph.D.
UT San Antonio
Bertha Madras, Ph.D.
Harvard Medical School
Peter Kalivas, Ph.D.
Med U South Carolina
Eric Nestler, M.D., Ph.D.
Southwestern University
Herb Kleber, M.D.
Columbia University
Scott Reines, M.D., Ph.D.
Johnson & Johnson
George Koob, Ph.D.
Scripps Research Institute
Ray White, Ph.D.
UC San Francisco
Mary Jeanne Kreek, M.D.
Rockefeller University
NIDA Staff
Denise Pintello, Ph.D. M.S.W.
Science Writer (Contractor)
Jennifer Elcano, M.A.
Summary of Workgroup Recommendations
Internal Organization
Create a SAB to advise on internal efficiencies & decision
making
Interactions with other NIDA Divisions
Restructure relationships, especially with CCTN and IRP
Interactions with Pharmaceutical Companies
Establish NIDA as an asset to pharma for abuse liability
screening and clinical trials
Role of Genetics
Develop a human genetic resource via collaborations
between MDP and CCTN
Medications Development Scientific Workgroup
Members
First Meeting:
Hyatt Regency Hotel
Bethesda, MD
March 21-22, 2005
Kenneth Davis, M.D.
Lisa H. Gold, Ph.D.
Suneel Gupta, Ph.D.
Bankole Johnson, M.D., Ph.D.
Peter Kalivas, Ph.D.
Herb Kleber, M.D.
Thomas R. Kosten, M.D.
Susan Learned-Coughlin, Pharm.D, Ph.D.
Bertha Madras, Ph.D.
Eric Nestler, M.D., Ph.D.
Charles P. O’Brien, M.D., Ph.D.
Kenner Rice, Ph.D.
Interactions With Other NIDA Components
•
•
Starting Treatment with Agonist Replacement
Therapies (START) Study (with CCTN)
Institute-wide Workgroup with Representatives
from CCTN, IRP and all Extramural Divisions
National Institute on Drug Abuse
Office of the Director
Special Populations Office
Nora D. Volkow, MD
Director
Timothy P. Condon, Ph.D.
Deputy Director
Director, AIDS Research
Laura S. Rosenthal
Associate Director
for Management
Office of
Extramural
Affairs
Teresa Levitin, PhD
Division of
Basic Neurosciences
& Behavior Research
DBNBR
David Shurtleff, PhD
Office of Planning
& Resource
Management
Laura Rosenthal
Office of
Science Policy &
Communications
Timothy Condon, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
Division of
Epidemiology,
Services &
Prevention Research
Frank Vocci, PhD
Wilson Compton, MD, MPE
Center for the
Clinical Trials
Network
Betty Tai, PhD
Division of Clinical
Neuroscience,
Development &
Behavioral
Treatment
Joseph Frascella, PhD
Intramural
Research
Program
Barry Hoffer, MD, PhD
NIH Roadmap ACCELERATING MEDICAL DISCOVERY TO IMPROVE HEALTH
NIH IC Directors’ Roadmap Retreat
April 20, 2005
•
Molecular Libraries
NIH Neuroscience Blueprint
FY 2005 (Tap =
Project Team
GENSAT expansion
Neurobiology of Disease
Training Supplements
Neuroscience Inventory
BRAIN-BEHAVIOR AND HEALTH ROADMAP
GENES
QUESTIONS
APPROACH
NETWORK/INFRASTRUCTURE
What genes are involved in Genomic Resources
Gene sequence for mouse
BRAIN-BEHAVIOR AND HEALTH ROADMAP
brain development and
PROTEIN
function?
QUESTION
Gene Maps for Mouse APPROACH
What proteins are involved in
brain development
andfor rat
gene sequence
function?
Structure
What is their 3-D structure
and interactions with other
human genome
proteins?
comparative genomics of multiple species
Mammalian Gene Collection (MGC)
Lead IC
NINDS
NIMH
NIDA
NETWORK/INFRASTRUCTURE
Protein Data bank--s
BRAIN-BEHAVIOR AND HEALTH ROADMAP
CELL
NIDA crystal structure contract -- NRL Cambridge Univ
QUESTIONS
APPROACH
NETWORK/INFRASTRUCTURE
Riken
Laboratories
Protein Structure and Function
How
many
cell types are
BRAIN-BEHAVIOR AND HEALTH ROADMAP
Cell-centered database
there
in the brain?
CIRCUITS AND
NIGMS Protein structure project--s
PATHWAYS
QUESTIONS
NIGMS PA: "Structural Biology of Membrane
Proteins"
Structure Prediction for Membrane Proteins
Subcellular Elements
How is Montreal
the brainproteomics
organized?
Rice University Functional Annotation
NETWORK/INFRASTRUCTURE
BRAIN-BEHAVIOR
AND HEALTH ROADMAP
Neuroinformatics
Website
BEHAVIOR
QUESTIONS
APPROACH
NIH
MRI Study of Normal Brain Development
What are
the genetic
Cognitive
(NICHD,
NIMH,
NINDS,and
NIDA includes
DTI,and
MRS)
Genome/Proteome
Kyoto Encyclopedia of genes and genomes (pathways)
neurobiological determinants Integrative Behavioral
SNP consortium
Schreiber
Center cell
on Protein
& Small Molecules NSF -- cell types
What
determines
type? Function
Cell Types
of behavior?
Neuroscience
What are the circuits that
Model
organism, nervous system
formation
Mouse Genome Database Project (MGD)
ENCODE (EncyclopediaComputation
of DNA Elements)
Cell Physiology underlie the various brain
BISTI
What are the interactions
Automatic vs. controlled
Rikken
Proteomics Standards Initiative
Analytical Tools functions?
Human Brain Project
amongBioimaging
brain, behavior
and
Processing
Caltech
Center
Mutants: reverse
German Gene Trap Consortium
NIHdo
roadmap
for membrane
protein production
Membrane Proteins How
cells interact
with Cellular
Interactions
environment?
XSPAN
- cross-species developmental anatomy
genetics
Executive Function
ontology integration system
one
another? Protein resources
Kumamoto University
Membrane
Edinburgh Ontology of Human Developmental
National Center for Microscopy & Imaging Research
Anatomy
Learning and Memory
Neurochemistry
Mary Kennedy's Program Project, CALTECH
Cell regeneration in brain
Protein profiling
Imaging Mass Spectrometry
-- mouse brain
How isManitoba
protein expression
Institute of Cell Biology, Centre for
Neural Basis of
regulated
in the brain?
Mammalian
Functional Genomics
Biopathways Consortium
Emotion, Motivation,
Interactions
University of California Resource
of Gene Trap
and Mood
What isInsertions
the role of a given
Attention
protein in normal and
Synapse modification
DopaNet
NIH roadmap
networks
pathways and
pathological
brainConsortium
function?
Protein
Gene trap
Dynamic
changesforduring
the &Databases
Molecular libraries initiative
Language
HUPO, Human brain proteome project
Lexicon Genetics Corp.
lifespan
of
brain
cells
resources
Companies
Consciousness
Montreal proteomics
Harvard University Institute of Proteomics
Virtual Cell
Timing
NIGMS Glue grant: "Lipids Map"
Lipids
NINDS P01 on Lipids and Neuronal Cell Signaling
Deltagen
Alliance for Cellular Signalling
NIGMS Glue grant on Functional Glycomics
Sugars
Velocigene/Regeneron
How are neuronal circuits
Neuroanatomy
Brain banks (Armed Forces, NIMH, NINDS,
Databases and
SelectionNICHD,
SigPath
TBASE
established, organized and
NIA)
DOE -- Oakridge National Laboratory
Database of Gene Knockouts in Mice that Affect
Biomedical Informatics Research Network (BIRN)
maintained?
Uni-Prot/Swiss Prot/EBI--s
Nervous System Phenotypes and Function Index
NIH Brain Molecular Anatomy Group
American Type Culture Collection (ATCC)
Search engines (AmiGO) (gene ontology)
ExPASY Molecular Biology Server
European Collection of Cell Cultures (ECACC) LONI: Laboratory of Neuroimaging
National Center for Macromolecular Imaging
Cell Line Data Base (CLDB)
ICBM: International Consortium for Brain Mapping
(NCRR)
loss of function tools:siRNA and shRNA
mouse genome informatics: jax
CGAP:Cancer Gene Anatomy Project
Function
HAPMAP
FY 2006 (Tap =
0.15%)
BioPathways Consortium
Protein Interaction Networks
Protein Interaction Domains
APPROACH
Development
NIH Cell Culture Center
Brain, cellular and sub-cellular anatomy
Atlas of Neurocytology
Sense Lab
Brain Ontology (BrainML)
Cellular and molecular imaging
Biopathways consortium
BIRN (Biomedical Informatics Research Network)
Sleep
Institutes
Mind/Body integration;
Allen Institute for Brain Sciences
Autonomic NS
Brain Regulation of
Brain Atlases
ANS
Gastrological
Lung and cardiac
Brain, cellular and sub-cellular anatomy
Psychoneuroimmunolog
Whole Brain Atlas
y
Internet Brain Segmentation Repository
Behavioral development
Primate Brain Maps
Human Brain Project
NETWORK/INFRASTRUCTURE
NIH MRI Study of Normal Brain Development
(NICHD, NIMH, NINDS, NIDA)
Mouse mutagenesis centers (NIMH)
Patient cohorts for neuropshychology studies -- brain
injury, neurosurgical (McGill, Iowa, Salk, VA units)
Montreal Neurological Institute
National Center on Medical Rehabilitation
Research (NCMRR/NICHD) -- Traumatic brain
injury
Laboratory for Cognitive Neuroscience, Salk
Cognitive Neuroscience Patient Registry (Iowa)
Center for Biological Timing (NSF STC; UVA)
Center for Behavioral Neuroscience (NSF STC,
Atlanta)
Trans-NIH Cognitive Neuroscience Consortium
Center for the Study of Mind, Brain, and Behavior
(Princeton)
Center for Mind and Brain, UC Davis
Neuroimaging Laboratory (Baylor)
Center for Neural Basis of Cognition
National Center on Sleep Disorders Research
(NHLBI)
OBSSR Mind/Body Centers
National Children's Study
NIDDK
Maternal Lifestyle Study
Hecht Foundation
Health Emotions Institute, Wisconsin
OBSSR Coordinating Committee
TTRCs: Transdisciplinary Tobacco Research
Centers
Project Team
Core Grants
Neuromouse
Training
1.
2.
3.
0.30%)
Lead IC
NINDS
NIMH
NIDA
Neuroimaging Training
Computational Neuroscience
Neurobiology of Disease
Neuroscience Blueprint ‘06
Training Project Team
Laurence Stanford, NIDA, Co-Chair
Susan Weiss, NIDA, Co-Chair
Beth Babecki, NIDA
Robert Baughman, NINDS
Allison Chausmer, NIDA
Alison Cole, NIGMS
Nancy Desmond, NIMH
Gayathri J Dowling, NIDA
Dennis Glanzman, NIMH
Lindsey Grandison, NIAAA
Steven Grant, NIDA
Kevin Hardwick, NIDCR
Deborah Henken, NICHD
Chyren Hunter, NEI
Henry Khachaturian, NIBIB
Teresa Levitin, NIDA
Yuan Liu, NINDS
Susan Molchan, NIA
Andrew Monjan, NIA
Juanita Nelson, NIDA
Nancy Pearson, NCCAM
Nancy Pilotte, NIDA
Suman Rao King, NIDA
Charles Sharp, NIDA
Carol Shreffler, NIEHS
David Shurtleff, NIDA
Karen Skinner, NIDA
Roger Sorensen, NIAAA
Daniel Sklare, NIDCD
Mark Swieter, NIDA
Meredith Temple-O’Connor, NIBIB
Susan Volman, NIDA
Kenneth Whang, NSF
Training Subgroups
•
•
•
Neuroimaging
Neurobiology of Disease
Computational Neuroscience
Interdisciplinary Predoctoral Training
in Neuroscience Imaging:
Integrating First Principles and Application
Purpose:
To develop interdisciplinary, predoctoral training
programs that integrate imaging technologies,
neuroscience applications, and the underlying
neurobiological principles with the aim of creating a
cadre of scientists who can optimally utilize imaging
technologies to address neuroscience questions
Neurobiology of Disease:
Training in Translational Research
in Neuroscience
Purpose:
Train MD, PhD and other scientists in the
multiple theories, techniques, analytic strategies
and objectives of research on the neurobiology
of disease
Computational Neuroscience:
From Model to Biology and Back Again
Purpose:
Interdisciplinary training of pre- and postdoctoral
fellows competent in the theories, principles and
application of the physical, computer, or
mathematical sciences to experimental neuroscience
National Institute on Drug Abuse
Office of the Director
Special Populations Office
Nora D. Volkow, MD
Director
Timothy P. Condon, Ph.D.
Deputy Director
Director, AIDS Research
Laura S. Rosenthal
Associate Director
for Management
Office of
Extramural
Affairs
Teresa Levitin, PhD
Division of
Basic Neurosciences
& Behavior Research
David Shurtleff, PhD
Office of Planning
& Resource
Management
Laura Rosenthal
Office of
Science Policy &
Communications
Timothy Condon, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
Division of
Epidemiology,
Services &
Prevention Research
Frank Vocci, PhD
Wilson Compton, MD, MPE
Center for the
Clinical Trials
Network
Betty Tai, PhD
Division of Clinical
Neuroscience,
Development &
Behavioral
Treatment
DCNDBT
Intramural
Research
Program
Joseph Frascella, PhD
Barry Hoffer, MD, PhD
MRI Study of Normal Brain Development
(N=500)
Create a database of behavioral
and brain MRI development
data for 0-18 years
Analyze structural-behavioural
relationships
The National Institute on Drug Abuse
Develop technique for
dissemination of results
Neurobiology of Behavioral Treatment:
Recovery of Brain Structure and Function
RFA-DA-05-006
22 Applications Received
Consequences of Drug Abuse & Alcohol
Exposure on Brain & Behavioral Development
RFA-DA-05-007
Issued with NIAAA -- 36 Applications Received
HIV & Drug Abuse Interventions Among
Pregnant Women in Drug Abuse Treatment
RFA-DA-05-008
16 Applications Received
National Institute on Drug Abuse
Office of the Director
Special Populations Office
Nora D. Volkow, MD
Director
Timothy P. Condon, Ph.D.
Deputy Director
Director, AIDS Research
Laura S. Rosenthal
Associate Director
for Management
Office of
Extramural
Affairs
Teresa Levitin, PhD
Division of
Basic Neurosciences
& Behavior Research
David Shurtleff, PhD
Office of Planning
& Resource
Management
Laura Rosenthal
Office of
Science Policy &
Communications
Timothy Condon, PhD
Division of
Pharmacotherapies &
Medical Consequences
of Drug Abuse
Division of
Epidemiology,
Services &
Prevention Research
Frank Vocci, PhD
Wilson Compton, MD, MPE
DESPR
Center for the
Clinical Trials
Network
Betty Tai, PhD
Division of Clinical
Neuroscience,
Development &
Behavioral
Treatment
Joseph Frascella, PhD
Intramural
Research
Program
Barry Hoffer, MD, PhD
Effectively Breaking the Cycle
of Drugs and Crime:
Research & Treatment Provide the Answers
Sponsored by
The Friends of NIDA
March 15, 2005
CJ-DATS Update
Criminal Justice Drug Abuse Treatment Studies
• 6 studies in the field focused on:
– Reducing HIV risk behavior
– Screening for mental illness
– Transitioning from prison to community
9 Research
Centers
1 Coordinating Center
• 2 juvenile justice studies being developed
– Community re-entry and HIV risk behaviors
• 2 HIV studies being developed:
– Men
– Women
www.cjdats.org
CASA
Primary Care
Meeting
Screening and Intervention for Youth in
Primary Care Settings
RFA-DA-04-006
Issued with SAMHSA, HRSA and AHCPR
Purpose: Expand the role of primary care in addressing
problem drug use—especially marijuana—among
youth in the pre-dependency phase of drug abuse.
36 applications
7 awards made in September, 2004:
4 Behavioral Treatment Research
2 Health Services Research
1 Prevention Research
Congressional Hearings
Consequences of the Abuse of
Anabolic Steroids
Testimony before the Committee on
Government Reform -- March 17, 2005
Fiscal Year 2006 Budget Request
Testimony before the:
House Subcommittee on Labor-HHS-Education Approp. -- March 9, 2005
Senate Subcommittee on Labor-HHS-Education Approp. -- April 6, 2005
Methamphetamine Abuse
Testimony before the Senate Subcommittee on Labor, HHS, Education, &
Related Agencies -- Committee on Appropriations -- April 21, 2005
Substance Abuse and Mental Health Research & Services
Testimony before the House Subcommittee on Labor, HHS & Education
Committee on Appropriations -- April 27, 2005
NIDA Also Co-sponsored or Had Involvement in…
CSAT Annual Grantees Meeting on Adolescent
Treatment
March 23, 2005
2005 SAMHSA/NIDA Buprenorphine Summit
April 11-12, 2005
Impact of Drug Formulation on Abuse Liability,
Safety and Regulatory Decisions (CPDD)
April 19-20, 2005
Methamphetamine Research Workgroup Meeting
March 9-10, 2005
PRIDE 2005 – A Special Research Track from NIDA
April 6-9, 2005
9th Annual
PRISM Awards Event
Beverly Hills Hotel
April 28, 2005
Event will air as a
one-hour TV special
on FX Network
September 4, 2005 at 5:00pm
Cannabis Dependence Treatment:
Where We Are, Where We Are Going
Issue Workshop
Tuesday, May 24, 2005 -- 11:00 am to 12:30 pm
Increases in Opioid Analgesic Abuse:
Concerns and Strategies
Symposium
Tuesday, May 24, 2005 -- 2:00 pm to 5:00 pm
New Scientific Advances in the
Neurobiology of Behavior
Symposium
Wednesday, May 25, 2005 -- 2:00 pm to 5:00 pm
Neurobiology of Compulsive
Reward-Seeking
Symposium
Thursday, May 26, 2005 -- 2:00 pm to 5:00 pm
NIDA-Sponsored Events at CPDD 2005
A record number of posters from CTN research
will be presented at this year’s meeting
June 17th
June 18th
International Forum (June 17th - 19th)
Review & Evaluation of NIDA Targets for
Potential NIH Roadmap Library
Screening Efforts
NIDA Tutorials
Translating Basic Research from Neural,
Behavioral, & Social Sciences to Prevention
June 20th
Proteomics & Its Application to Drug Abuse
Mice Tales: Novel Insights Into
Understanding Addiction
NIDA Training Mixer
June 21st
NIDA/CPDD Grant-writing Workshop
June 22nd
Pharmacogenetics & Drug Abuse Research
Commissioned articles
highlighting current progress
in the neurobiology
of feeding regulation,
energy metabolism and obesity
Sponsored by the
Obesity Research
Task Force of the
National Institutes of Health
•
•
•
•
NIDA
NIDDK
NIAAA
NHLBI